Zobrazeno 1 - 4
of 4
pro vyhledávání: '"George S. Melchor"'
Autor:
Jingwen Hu, George S. Melchor, Dimitrios Ladakis, Joan Reger, Hee Won Kim, Kelly A. Chamberlain, Nataliia V. Shults, Helena C. Oft, Victoria N. Smith, Lauren M. Rosko, Erqiu Li, Maryna Baydyuk, Meng-Meng Fu, Pavan Bhargava, Jeffrey K. Huang
Publikováno v:
npj Regenerative Medicine, Vol 9, Iss 1, Pp 1-18 (2024)
Abstract Regulation of myeloid cell activity is critical for successful myelin regeneration (remyelination) in demyelinating diseases, such as multiple sclerosis (MS). Here, we show aromatic alpha-keto acids (AKAs) generated from the amino acid oxida
Externí odkaz:
https://doaj.org/article/2b9465e4fbef4a74a3282cd27dd536a3
Autor:
Lauren M. Rosko, Tyler Gentile, Victoria N. Smith, Zeeba Manavi, George S. Melchor, Jingwen Hu, Nataliia V. Shults, Chris Albanese, Yichien Lee, Olga Rodriguez, Jeffrey K. Huang
Publikováno v:
The Journal of Neuroscience. 43:1143-1153
Cerebral creatine deficiency syndrome (CCDS) is an inborn error of metabolism characterized by intellectual delays, seizures, and autistic-like behavior. However, the role of endogenously synthesized creatine on CNS development and function remains p
Autor:
Ryan M. Downey, K. Breana Downey, Jessica Jacobs, Holly Korthas, George S. Melchor, Andrew Speidell, Hannah Waguespack, Susan E. Mulroney, Adam K. Myers
Publikováno v:
Adv Physiol Educ
Graduate students intending to pursue an academic career in the sciences have much to gain by learning to teach science but often have limited training opportunities. In response to this need, we designed a one-semester course, Learning Design in Sci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c50015bc0b273485ea7d6b87e15f9a59
https://europepmc.org/articles/PMC9639774/
https://europepmc.org/articles/PMC9639774/
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system characterized by a complex lesion microenvironment. Although much progress has been made in developing immunomodulatory treatments to reduce myelin